Stay updated on ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial

Sign up to get notified when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The two screenshots show the same version history entries with no substantive updates to study data or status; any difference appears cosmetic. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T21:26:20.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Major update to operating-status notice and versioning (v3.2.0) with a new date window; older status and revision were removed.
    Difference
    14%
    Check dated 2025-10-06T07:52:47.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Updated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.
    Difference
    0.3%
    Check dated 2025-09-29T04:19:37.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page revision updated from v3.0.1 to v3.0.2. The Back to Top element was removed.
    Difference
    0.8%
    Check dated 2025-09-14T21:52:51.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.8%
    Check dated 2025-09-07T18:52:21.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and specific study status dates, while removing various location-related terms.
    Difference
    10%
    Check dated 2025-08-31T12:25:31.000Z thumbnail image

Stay in the know with updates to ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.